[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$aqst](/topic/$aqst)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$aqst/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$aqst/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +56%  
**1 Month**: XX% +4%  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-09-01  

**Most Supportive Themes**
- **Bullish on Anaphylm Approval:** (45%) Many posts express optimism about the potential FDA approval of Anaphylm, Aquestive Therapeutics' epinephrine film, and its market impact.
- **Positive Analyst Ratings and Price Targets:** (25%) Several posts highlight positive analyst ratings and increased price targets for $AQST, contributing to a bullish sentiment.
- **Community Support and Encouragement:** (15%) There is a strong sense of community, with individuals sharing positive experiences, offering encouragement, and celebrating gains.
  
**Most Critical Themes**
- **Concerns about Side Effects and Administration:** (10%)  Some posts raise concerns about potential side effects and the practicality of administering Anaphylm, particularly during vomiting.
- **Skepticism and Short Seller Activity:** (5%)  Some posts mention skepticism and the presence of short sellers, who may be spreading negative sentiment.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| Reddit  | X        | X%  | XX      | X%  | X        | X% |
| TikTok  | X        | X%  | X       | X%  | X        | X% |
| X       | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |